chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Hypercapnia, Intensive care, Lung opacity, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin normal
Clinical narrative: "Deceased (11.17.21); Hospitalized (11.16.21); COVID-19 positive (11.13.21); Fully vaccinated. x2  Discharge Disposition: Deceased   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CO2 narcosis [R06.89] Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1] Acute respiratory failure with hypoxia and hypercapnia [J96.01, J96.02]   HOSPITAL COURSE: 73 yo male who is a resident of facility.  Patient presented to the emergency room with several days of worsening dyspnea and decreased responsiveness.  He had had a positive COVID-19 test on November 13. In the emergency department he had a blood gas demonstrating a pH of 7.16 with a P CO2 of 104. He was do not resuscitate and do not intubate status.  He was treated with BiPAP in the emergency department and had improvement in his blood gas to a pH of 7.26 and pCO2 of 75, with resulting improved alertness.  He was admitted to intensive care unit and started on IV remdesivir and IV Decadron and was continued on BiPAP.  A repeat blood gas at 1:55 a.m. showed pH 7.04 and a pCO2 of 120, and was associated with decreased responsiveness.. He subsequently had oxygen desaturation and became completely unresponsive.  In the morning repeat arterial blood gas showed a pH of 6.83 with a pCO2 greater than 150. I contacted his legal guardian and reported his declining condition with a grave prognosis.  He subsequently developed bradycardia followed by ventricular fibrillation and expired at 10:56 a.m..
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume increased, Mean platelet volume increased, Metabolic function test abnormal, Myocardial infarction, Oxygen saturation decreased
Clinical narrative: "Deceased (11.17.21); Hospitalized (11.16.21); COVID-19 positive (11.13.21); Fully vaccinated. x2  Discharge Disposition: Deceased   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CO2 narcosis [R06.89] Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1] Acute respiratory failure with hypoxia and hypercapnia [J96.01, J96.02]   HOSPITAL COURSE: 73 yo male who is a resident of facility.  Patient presented to the emergency room with several days of worsening dyspnea and decreased responsiveness.  He had had a positive COVID-19 test on November 13. In the emergency department he had a blood gas demonstrating a pH of 7.16 with a P CO2 of 104. He was do not resuscitate and do not intubate status.  He was treated with BiPAP in the emergency department and had improvement in his blood gas to a pH of 7.26 and pCO2 of 75, with resulting improved alertness.  He was admitted to intensive care unit and started on IV remdesivir and IV Decadron and was continued on BiPAP.  A repeat blood gas at 1:55 a.m. showed pH 7.04 and a pCO2 of 120, and was associated with decreased responsiveness.. He subsequently had oxygen desaturation and became completely unresponsive.  In the morning repeat arterial blood gas showed a pH of 6.83 with a pCO2 greater than 150. I contacted his legal guardian and reported his declining condition with a grave prognosis.  He subsequently developed bradycardia followed by ventricular fibrillation and expired at 10:56 a.m..
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: PCO2 increased, Platelet count decreased, Pleural effusion, Pleural thickening, Positive airway pressure therapy
Clinical narrative: "Deceased (11.17.21); Hospitalized (11.16.21); COVID-19 positive (11.13.21); Fully vaccinated. x2  Discharge Disposition: Deceased   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CO2 narcosis [R06.89] Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1] Acute respiratory failure with hypoxia and hypercapnia [J96.01, J96.02]   HOSPITAL COURSE: 73 yo male who is a resident of facility.  Patient presented to the emergency room with several days of worsening dyspnea and decreased responsiveness.  He had had a positive COVID-19 test on November 13. In the emergency department he had a blood gas demonstrating a pH of 7.16 with a P CO2 of 104. He was do not resuscitate and do not intubate status.  He was treated with BiPAP in the emergency department and had improvement in his blood gas to a pH of 7.26 and pCO2 of 75, with resulting improved alertness.  He was admitted to intensive care unit and started on IV remdesivir and IV Decadron and was continued on BiPAP.  A repeat blood gas at 1:55 a.m. showed pH 7.04 and a pCO2 of 120, and was associated with decreased responsiveness.. He subsequently had oxygen desaturation and became completely unresponsive.  In the morning repeat arterial blood gas showed a pH of 6.83 with a pCO2 greater than 150. I contacted his legal guardian and reported his declining condition with a grave prognosis.  He subsequently developed bradycardia followed by ventricular fibrillation and expired at 10:56 a.m..
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Protein total normal, QRS axis abnormal, Red blood cell count decreased, Red blood cell nucleated morphology, Red cell distribution width normal
Clinical narrative: "Deceased (11.17.21); Hospitalized (11.16.21); COVID-19 positive (11.13.21); Fully vaccinated. x2  Discharge Disposition: Deceased   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CO2 narcosis [R06.89] Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1] Acute respiratory failure with hypoxia and hypercapnia [J96.01, J96.02]   HOSPITAL COURSE: 73 yo male who is a resident of facility.  Patient presented to the emergency room with several days of worsening dyspnea and decreased responsiveness.  He had had a positive COVID-19 test on November 13. In the emergency department he had a blood gas demonstrating a pH of 7.16 with a P CO2 of 104. He was do not resuscitate and do not intubate status.  He was treated with BiPAP in the emergency department and had improvement in his blood gas to a pH of 7.26 and pCO2 of 75, with resulting improved alertness.  He was admitted to intensive care unit and started on IV remdesivir and IV Decadron and was continued on BiPAP.  A repeat blood gas at 1:55 a.m. showed pH 7.04 and a pCO2 of 120, and was associated with decreased responsiveness.. He subsequently had oxygen desaturation and became completely unresponsive.  In the morning repeat arterial blood gas showed a pH of 6.83 with a pCO2 greater than 150. I contacted his legal guardian and reported his declining condition with a grave prognosis.  He subsequently developed bradycardia followed by ventricular fibrillation and expired at 10:56 a.m..
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Scoliosis, Serum ferritin increased, Staphylococcus test positive
Clinical narrative: "Deceased (11.17.21); Hospitalized (11.16.21); COVID-19 positive (11.13.21); Fully vaccinated. x2  Discharge Disposition: Deceased   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CO2 narcosis [R06.89] Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1] Acute respiratory failure with hypoxia and hypercapnia [J96.01, J96.02]   HOSPITAL COURSE: 73 yo male who is a resident of facility.  Patient presented to the emergency room with several days of worsening dyspnea and decreased responsiveness.  He had had a positive COVID-19 test on November 13. In the emergency department he had a blood gas demonstrating a pH of 7.16 with a P CO2 of 104. He was do not resuscitate and do not intubate status.  He was treated with BiPAP in the emergency department and had improvement in his blood gas to a pH of 7.26 and pCO2 of 75, with resulting improved alertness.  He was admitted to intensive care unit and started on IV remdesivir and IV Decadron and was continued on BiPAP.  A repeat blood gas at 1:55 a.m. showed pH 7.04 and a pCO2 of 120, and was associated with decreased responsiveness.. He subsequently had oxygen desaturation and became completely unresponsive.  In the morning repeat arterial blood gas showed a pH of 6.83 with a pCO2 greater than 150. I contacted his legal guardian and reported his declining condition with a grave prognosis.  He subsequently developed bradycardia followed by ventricular fibrillation and expired at 10:56 a.m..
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Supraventricular tachycardia, Tracheal deviation, Unresponsive to stimuli, Ventricular extrasystoles, Ventricular fibrillation
Clinical narrative: "Deceased (11.17.21); Hospitalized (11.16.21); COVID-19 positive (11.13.21); Fully vaccinated. x2  Discharge Disposition: Deceased   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CO2 narcosis [R06.89] Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1] Acute respiratory failure with hypoxia and hypercapnia [J96.01, J96.02]   HOSPITAL COURSE: 73 yo male who is a resident of facility.  Patient presented to the emergency room with several days of worsening dyspnea and decreased responsiveness.  He had had a positive COVID-19 test on November 13. In the emergency department he had a blood gas demonstrating a pH of 7.16 with a P CO2 of 104. He was do not resuscitate and do not intubate status.  He was treated with BiPAP in the emergency department and had improvement in his blood gas to a pH of 7.26 and pCO2 of 75, with resulting improved alertness.  He was admitted to intensive care unit and started on IV remdesivir and IV Decadron and was continued on BiPAP.  A repeat blood gas at 1:55 a.m. showed pH 7.04 and a pCO2 of 120, and was associated with decreased responsiveness.. He subsequently had oxygen desaturation and became completely unresponsive.  In the morning repeat arterial blood gas showed a pH of 6.83 with a pCO2 greater than 150. I contacted his legal guardian and reported his declining condition with a grave prognosis.  He subsequently developed bradycardia followed by ventricular fibrillation and expired at 10:56 a.m..
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count normal
Clinical narrative: "Deceased (11.17.21); Hospitalized (11.16.21); COVID-19 positive (11.13.21); Fully vaccinated. x2  Discharge Disposition: Deceased   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: CO2 narcosis [R06.89] Acute hypoxemic respiratory failure due to COVID-19 [U07.1, J96.01] COVID-19 [U07.1] Acute respiratory failure with hypoxia and hypercapnia [J96.01, J96.02]   HOSPITAL COURSE: 73 yo male who is a resident of facility.  Patient presented to the emergency room with several days of worsening dyspnea and decreased responsiveness.  He had had a positive COVID-19 test on November 13. In the emergency department he had a blood gas demonstrating a pH of 7.16 with a P CO2 of 104. He was do not resuscitate and do not intubate status.  He was treated with BiPAP in the emergency department and had improvement in his blood gas to a pH of 7.26 and pCO2 of 75, with resulting improved alertness.  He was admitted to intensive care unit and started on IV remdesivir and IV Decadron and was continued on BiPAP.  A repeat blood gas at 1:55 a.m. showed pH 7.04 and a pCO2 of 120, and was associated with decreased responsiveness.. He subsequently had oxygen desaturation and became completely unresponsive.  In the morning repeat arterial blood gas showed a pH of 6.83 with a pCO2 greater than 150. I contacted his legal guardian and reported his declining condition with a grave prognosis.  He subsequently developed bradycardia followed by ventricular fibrillation and expired at 10:56 a.m..
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Pain, Pain in extremity
Clinical narrative: same night, arm feels very sore, went away and came back after using arm, accompanied by chills
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Condition aggravated, Endoscopy, Exploratory operation
Clinical narrative: Immediate and extreme back pain next day after second vaccine injection. On May 1, 2021 developed shoulder pain which lasted for 3 days. On May 18 got shoulder pain again, became feverish, vomiting and had to go to ER by ambulance. Had emergency exploratory surgery early on May 19 in abdominal cavity due to extreme shoulder pain and air in cavity. Surgeon found a GASTRIC PERFORATION in stomach that he patched up.  Abdominal leakage and high white blood count, fever. This was the cause of the shoulder pain. Spent over one week in the hospital to recover from this surgery. There was NO prior history of gastric ulcers.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Gastric perforation, Gastrorrhaphy, Helicobacter test negative, Immediate post-injection reaction, Laboratory test normal
Clinical narrative: Immediate and extreme back pain next day after second vaccine injection. On May 1, 2021 developed shoulder pain which lasted for 3 days. On May 18 got shoulder pain again, became feverish, vomiting and had to go to ER by ambulance. Had emergency exploratory surgery early on May 19 in abdominal cavity due to extreme shoulder pain and air in cavity. Surgeon found a GASTRIC PERFORATION in stomach that he patched up.  Abdominal leakage and high white blood count, fever. This was the cause of the shoulder pain. Spent over one week in the hospital to recover from this surgery. There was NO prior history of gastric ulcers.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting, White blood cell count increased
Clinical narrative: Immediate and extreme back pain next day after second vaccine injection. On May 1, 2021 developed shoulder pain which lasted for 3 days. On May 18 got shoulder pain again, became feverish, vomiting and had to go to ER by ambulance. Had emergency exploratory surgery early on May 19 in abdominal cavity due to extreme shoulder pain and air in cavity. Surgeon found a GASTRIC PERFORATION in stomach that he patched up.  Abdominal leakage and high white blood count, fever. This was the cause of the shoulder pain. Spent over one week in the hospital to recover from this surgery. There was NO prior history of gastric ulcers.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Itchy rash developed on chest and upper stomach soon after vaccinated. Mostly gone by morning
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash, Urticaria
Clinical narrative: *Intense itching more intense at night *Rash - bumps and whelps on arms, chest, shoulders, upper back, lower back and stomach *Redness of face on jaw and cheeks
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Exposure during pregnancy, Nausea
Clinical narrative: Currently 33 weeks pregnant, estimated due date 1/2/22. Experiences light headedness, dizziness, nausea within 20-30 minutes after receiving the vaccine.
Age: 0.67
Sex: F
Vaccine: FLUR4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: none
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive contact unknown
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash erythematous
Clinical narrative: red rash bilateral forearms and chest. IM Benadryl 25mg right deltoid @ 1305
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: The nurse sated that she reconstituted the 5-11 year old  Pfizer Covid-19 vaccine with 1.8 ml of 0.9% of normal saline instead of 1.3 ml.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Loss of personal independence in daily activities, Malaise, Nasopharyngitis
Clinical narrative: Patient had a fever for approximately 3 days at times over 103 that was difficult to keep in control by keeping cool cloths on him under a fan and alternating tylenol and motrin. He said his body hurt and that he didn't feel well. He experienced significant congestion and he told his dad that it was hard to breath. I am not sure if it was hard to breath bc of congestion or if he was having any respiratory issues. He was significantly congested for several days. Patient stayed home from school due to his symptoms for 3 days. Patient saw a doctor who thought he probably picked up a cold at the exact same time he received his first covid vaccine dose, as Patient's 3 year old brother started experiencing the same symptoms approximately 5 days after Patient received his covid vaccine. It is just strange that a cold would happen at the exact same time that a covid vaccine was received. It is possible that it was a cold, but it is also possible that Patient had pretty significant symptoms in response to the covid vaccine. I thpught it should be reported in case other people experience the same thing.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative
Clinical narrative: Patient had a fever for approximately 3 days at times over 103 that was difficult to keep in control by keeping cool cloths on him under a fan and alternating tylenol and motrin. He said his body hurt and that he didn't feel well. He experienced significant congestion and he told his dad that it was hard to breath. I am not sure if it was hard to breath bc of congestion or if he was having any respiratory issues. He was significantly congested for several days. Patient stayed home from school due to his symptoms for 3 days. Patient saw a doctor who thought he probably picked up a cold at the exact same time he received his first covid vaccine dose, as Patient's 3 year old brother started experiencing the same symptoms approximately 5 days after Patient received his covid vaccine. It is just strange that a cold would happen at the exact same time that a covid vaccine was received. It is possible that it was a cold, but it is also possible that Patient had pretty significant symptoms in response to the covid vaccine. I thpught it should be reported in case other people experience the same thing.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Aggression, Agitation, Angiogram abnormal, Atrioventricular block first degree, Back pain
Clinical narrative: Hospitalized 11/12/2021; COVID-19 positive 11/12/2021; fully vaccinated  BRIEF OVERVIEW: Admission Date: 11/12/2021 Discharge Date: 11/15/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 81 y.o. female who presented to the Hospital with shortness of breath due to COVID-19. Also reported dry cough, nasal congestion, fatigue, diarrhea and chest pain radiating to her back.  At the ER she was tested positive for COVID-19. ECG showed first degree AV block, cardiac monitoring was put on. She was hypoxic when presenting to the ER at 89% room air, and was put on a 2L nasal cannula.  She was weaned off a oxygen requirement during the hospital course. Troponin levels were negative. CRP were trending downwards and d-dimer remained elevated in the 1,000's. She was given remdesivir and decadron in the ER and continued in admission. CTA thorax found massive distension of the cervical and thoracic esophagus.  On 11/14 early morning the patient became increasingly combative and agitated. She did not know her name and attempted to kick and yell at the staff. She attempted to remove her IV and put it in her mouth. She was given Haldol and she attempted to remove IV access again. Decadron was stopped later that morning and was only continued with remdesivir.  Patients daughter was able to calm the patient down and was calm during the rest of the hospital course.  On discharge day, the patient was orient to person place and time and was calm, non combative. She was sitting comfortably on room air. Remdesivir was discontinued and she was taken home by her daughter. PT and OT assessed her and recommended to be discharge to home with PT and OT home assist. RT evaluated the patient and reported that the patient does not need to be discharged with oxygen requirement
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein decreased, COVID-19, Cardiac monitoring, Chest pain, Cough
Clinical narrative: Hospitalized 11/12/2021; COVID-19 positive 11/12/2021; fully vaccinated  BRIEF OVERVIEW: Admission Date: 11/12/2021 Discharge Date: 11/15/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 81 y.o. female who presented to the Hospital with shortness of breath due to COVID-19. Also reported dry cough, nasal congestion, fatigue, diarrhea and chest pain radiating to her back.  At the ER she was tested positive for COVID-19. ECG showed first degree AV block, cardiac monitoring was put on. She was hypoxic when presenting to the ER at 89% room air, and was put on a 2L nasal cannula.  She was weaned off a oxygen requirement during the hospital course. Troponin levels were negative. CRP were trending downwards and d-dimer remained elevated in the 1,000's. She was given remdesivir and decadron in the ER and continued in admission. CTA thorax found massive distension of the cervical and thoracic esophagus.  On 11/14 early morning the patient became increasingly combative and agitated. She did not know her name and attempted to kick and yell at the staff. She attempted to remove her IV and put it in her mouth. She was given Haldol and she attempted to remove IV access again. Decadron was stopped later that morning and was only continued with remdesivir.  Patients daughter was able to calm the patient down and was calm during the rest of the hospital course.  On discharge day, the patient was orient to person place and time and was calm, non combative. She was sitting comfortably on room air. Remdesivir was discontinued and she was taken home by her daughter. PT and OT assessed her and recommended to be discharge to home with PT and OT home assist. RT evaluated the patient and reported that the patient does not need to be discharged with oxygen requirement
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Electrocardiogram abnormal, Fatigue, Fibrin D dimer
Clinical narrative: Hospitalized 11/12/2021; COVID-19 positive 11/12/2021; fully vaccinated  BRIEF OVERVIEW: Admission Date: 11/12/2021 Discharge Date: 11/15/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 81 y.o. female who presented to the Hospital with shortness of breath due to COVID-19. Also reported dry cough, nasal congestion, fatigue, diarrhea and chest pain radiating to her back.  At the ER she was tested positive for COVID-19. ECG showed first degree AV block, cardiac monitoring was put on. She was hypoxic when presenting to the ER at 89% room air, and was put on a 2L nasal cannula.  She was weaned off a oxygen requirement during the hospital course. Troponin levels were negative. CRP were trending downwards and d-dimer remained elevated in the 1,000's. She was given remdesivir and decadron in the ER and continued in admission. CTA thorax found massive distension of the cervical and thoracic esophagus.  On 11/14 early morning the patient became increasingly combative and agitated. She did not know her name and attempted to kick and yell at the staff. She attempted to remove her IV and put it in her mouth. She was given Haldol and she attempted to remove IV access again. Decadron was stopped later that morning and was only continued with remdesivir.  Patients daughter was able to calm the patient down and was calm during the rest of the hospital course.  On discharge day, the patient was orient to person place and time and was calm, non combative. She was sitting comfortably on room air. Remdesivir was discontinued and she was taken home by her daughter. PT and OT assessed her and recommended to be discharge to home with PT and OT home assist. RT evaluated the patient and reported that the patient does not need to be discharged with oxygen requirement
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Nasal congestion, Oesophageal disorder, Pain, SARS-CoV-2 test positive
Clinical narrative: Hospitalized 11/12/2021; COVID-19 positive 11/12/2021; fully vaccinated  BRIEF OVERVIEW: Admission Date: 11/12/2021 Discharge Date: 11/15/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 81 y.o. female who presented to the Hospital with shortness of breath due to COVID-19. Also reported dry cough, nasal congestion, fatigue, diarrhea and chest pain radiating to her back.  At the ER she was tested positive for COVID-19. ECG showed first degree AV block, cardiac monitoring was put on. She was hypoxic when presenting to the ER at 89% room air, and was put on a 2L nasal cannula.  She was weaned off a oxygen requirement during the hospital course. Troponin levels were negative. CRP were trending downwards and d-dimer remained elevated in the 1,000's. She was given remdesivir and decadron in the ER and continued in admission. CTA thorax found massive distension of the cervical and thoracic esophagus.  On 11/14 early morning the patient became increasingly combative and agitated. She did not know her name and attempted to kick and yell at the staff. She attempted to remove her IV and put it in her mouth. She was given Haldol and she attempted to remove IV access again. Decadron was stopped later that morning and was only continued with remdesivir.  Patients daughter was able to calm the patient down and was calm during the rest of the hospital course.  On discharge day, the patient was orient to person place and time and was calm, non combative. She was sitting comfortably on room air. Remdesivir was discontinued and she was taken home by her daughter. PT and OT assessed her and recommended to be discharge to home with PT and OT home assist. RT evaluated the patient and reported that the patient does not need to be discharged with oxygen requirement
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin normal
Clinical narrative: Hospitalized 11/12/2021; COVID-19 positive 11/12/2021; fully vaccinated  BRIEF OVERVIEW: Admission Date: 11/12/2021 Discharge Date: 11/15/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 81 y.o. female who presented to the Hospital with shortness of breath due to COVID-19. Also reported dry cough, nasal congestion, fatigue, diarrhea and chest pain radiating to her back.  At the ER she was tested positive for COVID-19. ECG showed first degree AV block, cardiac monitoring was put on. She was hypoxic when presenting to the ER at 89% room air, and was put on a 2L nasal cannula.  She was weaned off a oxygen requirement during the hospital course. Troponin levels were negative. CRP were trending downwards and d-dimer remained elevated in the 1,000's. She was given remdesivir and decadron in the ER and continued in admission. CTA thorax found massive distension of the cervical and thoracic esophagus.  On 11/14 early morning the patient became increasingly combative and agitated. She did not know her name and attempted to kick and yell at the staff. She attempted to remove her IV and put it in her mouth. She was given Haldol and she attempted to remove IV access again. Decadron was stopped later that morning and was only continued with remdesivir.  Patients daughter was able to calm the patient down and was calm during the rest of the hospital course.  On discharge day, the patient was orient to person place and time and was calm, non combative. She was sitting comfortably on room air. Remdesivir was discontinued and she was taken home by her daughter. PT and OT assessed her and recommended to be discharge to home with PT and OT home assist. RT evaluated the patient and reported that the patient does not need to be discharged with oxygen requirement
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product preparation issue
Clinical narrative: nurse gave entire vial of non-diluted pfizer vaccine
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache, Limb discomfort, Overdose
Clinical narrative: nurse gave entire vial of non-diluted pfizer vaccine
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product preparation error
Clinical narrative: nurse gave entire vial of non-diluted pfizer vaccine
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 11/09/2021. PATIENT FULLY VACCINATED ON 09/25/2021.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cancer surgery, Death, Post procedural complication, SARS-CoV-2 test positive
Clinical narrative: Post Vaccine Breakthrough. Was seen in clinic on 10/06/2021 for failing surgical site following surgery for cancer. Surgeon admitted tot the hospital for failing surgical site and was found to be positive for Covid 19 on admission due to routine swab.  During hospital stay resident continued to require multiple surgical interventions and did pass away on 10/26/21 at hospital. Does not appear that death was related to Covid but likely due to Cancer diagnosis with poor surgical outcome.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Surgery, Vaccine breakthrough infection
Clinical narrative: Post Vaccine Breakthrough. Was seen in clinic on 10/06/2021 for failing surgical site following surgery for cancer. Surgeon admitted tot the hospital for failing surgical site and was found to be positive for Covid 19 on admission due to routine swab.  During hospital stay resident continued to require multiple surgical interventions and did pass away on 10/26/21 at hospital. Does not appear that death was related to Covid but likely due to Cancer diagnosis with poor surgical outcome.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac flutter, Dysphagia, Dyspnoea, Electrocardiogram
Clinical narrative: On Nov 9th starting at 0930 I started to experience an fluttering sensation at the lower portion of my heart and a weird double thumping at the top of my heart. The thumping sensation made me feel like it was in my throat and that I couldn't swallow.  Sometimes it felt as if I couldn't catch my breath. It lasted three continuous hours before I went to the Emergency room
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Sensation of foreign body, X-ray
Clinical narrative: On Nov 9th starting at 0930 I started to experience an fluttering sensation at the lower portion of my heart and a weird double thumping at the top of my heart. The thumping sensation made me feel like it was in my throat and that I couldn't swallow.  Sometimes it felt as if I couldn't catch my breath. It lasted three continuous hours before I went to the Emergency room
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: Patient received first dose of Pfizer on 0729/21 and the second dose was received on 08/19/2021. This Registered nurse was giving patients booster shots per their request. I went through all the paper work and had separated the piles based on when they last received their dose. This patients paper work ended up in the pile with the patients who needed a booster. This patient received a 3rd shot on 11/18/2021 of a johnson and johnson vaccine. Prior to the shot this RN went over the fact sheet with this patient and he was unsure of when and what injection he received as it was at the hospital. No adverse reactions have been reported by this patient.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive contact unknown  Received booster on 10/26/21
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Fatigue, Headache, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Headache for several days, tired, sore throat.  I was potentially exposed to a coworker two consecutive days (Nov 8-9, 2021) who was not wearing a mask (I was wearing a mask) and was diagnosed with Covid Nov 10, 2021. Then another coworker who was wearing a mask and who I worked closely with was diagnosed with Covid on or around Nov 14, 2021. I decided to get tested. My appointment was 11:20 am on Nov 16, 2021. The results were sent to me about 8 am on Nov. 17, 2021. The test result was negative.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness, Nausea, Pallor
Clinical narrative: pt lost vision for few minutes, pale and nauseous
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: The patient was inadvertently administered 0.25 ml of Moderna instead of 0.5 ml Moderna second dose in primary series. Patient were monitored 15 minutes without issue and left clinic. Error noticed during data entry into Roster.  Medical provider notified and recommended the following. CDC recommendations of another 0.25 ml injection be given on the same day for optimal benefits. If patient refuses to come back for this dose, CDC will recognize 0.25 ml as an adequate second dose in the primary series. Therefore, in 6 months patients will be eligible for booster dose of 0.25 ml in 6 months.  Patient notified and returned the same day. An additional 0.25 ml dose of Moderna was administered to the patient. Patient was monitored 15 minutes without issues.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Chills, Hodgkin's disease, Idiopathic pulmonary fibrosis
Clinical narrative: Pt has Hodgkin's lymphoma (receiving weekly Rituxan treatments) and severe terminal idiopathic pulmonary fibrosis (requiring home oxygen).  Pt has a productive cough, fever, chills, and body aches.  Pt admitted with COVID-19 infection with pneumonia with acute on chronic respiratory failure.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen therapy, Pain, Productive cough, Pyrexia
Clinical narrative: Pt has Hodgkin's lymphoma (receiving weekly Rituxan treatments) and severe terminal idiopathic pulmonary fibrosis (requiring home oxygen).  Pt has a productive cough, fever, chills, and body aches.  Pt admitted with COVID-19 infection with pneumonia with acute on chronic respiratory failure.
Age: 52.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site inflammation, Injection site pain
Clinical narrative: inflammation and persistent moderate pain in left deltoid since vaccination 10-18-2021, improves with tylenol or advil but has not resolved
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Vomiting
Clinical narrative: I began coughing 2 days after the 2nd dose of the covid-19 Pfizer vaccine. It is a constant cough that has not gone away in 6 months and it began 2 days after the 2nd dose . Sometimes it causes me to throw up due to the excessive coughing fits
Age: 52.0
Sex: M
Vaccine: UNK
Symptoms: Tinnitus
Clinical narrative: Patient describes experiencing tinnitus after second dose of Pfizer in April. He also mentioned that he went to his PCP regarding this matter and they "shrugged" it off. When asked, the patient stated they did not examine his ear and has no other pre-existing conditions.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strength of vaccine.
Age: 55.0
Sex: F
Vaccine: UNK
Symptoms: Renal pain
Clinical narrative: Severe Kidney Pain
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Hive like rash.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Dysstasia, Fatigue, Pain
Clinical narrative: Tight/swollen throat within 15 minutes, Severe hip and lower back back within 18 hours lasting for two days, excessive fatigue within approximately 30 hours. Unable to stand completely upright for two days due to the pain even after taking 600 mg of Ibuprofen.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Throat tightness
Clinical narrative: Tight/swollen throat within 15 minutes, Severe hip and lower back back within 18 hours lasting for two days, excessive fatigue within approximately 30 hours. Unable to stand completely upright for two days due to the pain even after taking 600 mg of Ibuprofen.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strenth of vaccine remained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain of skin, Sensitive skin, Sleep disorder
Clinical narrative: For 6 hours my skin was extremely sensitive and  painful to the touch and I couldn?t sleep. It hurt if I touched my skin, if my clothes touched it, if a blanket touched it. It was all over my body.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 10/13/2021. PATIENT FULLY VACCINATED.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strenth of vaccine remained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Intensive care, Mental disorder, Metabolic encephalopathy
Clinical narrative: PMH:  ESRD, CHF, seizure disorder; hypothyroidism; hypercoagulable state, on chronic Coumadin; to ED due to altered mental state; AFR and positive for COVID; placed on BiPAP; condition worsened; to ICU; COVID protocols followed; metabolic encephalopathy; DNR; sepsis and shock; pt died in the hosp
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, SARS-CoV-2 test positive, Sepsis, Shock
Clinical narrative: PMH:  ESRD, CHF, seizure disorder; hypothyroidism; hypercoagulable state, on chronic Coumadin; to ED due to altered mental state; AFR and positive for COVID; placed on BiPAP; condition worsened; to ICU; COVID protocols followed; metabolic encephalopathy; DNR; sepsis and shock; pt died in the hosp
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Fatigue, Headache, Injection site pain, Injection site pruritus
Clinical narrative: On the Saturday I had soreness at the injection site and tiredness. On the Sunday; Headache, pain, itch and 4 inch diameter rash at injection site. In left earI had tenderness and my left underarm had pain. Monday tiredness gone but (pain, itch and 4 inch diameter rash at injection site. In left ear had tenderness and left underarm had pain) remained. On Tuesday I consulted with a pharmacist at the pharmacy where vaccine was administered and upon inspection was advised to place cold compress on injection site to remove swelling; and take ibruprophen for pain 3 times a days. I applied cold compres and took ibruprophen once a day. Today Thursday the swelling remains but the itch and rash are almost gone. Left inner ear and underarm tenderness has gone.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Injection site swelling, Pain in extremity
Clinical narrative: On the Saturday I had soreness at the injection site and tiredness. On the Sunday; Headache, pain, itch and 4 inch diameter rash at injection site. In left earI had tenderness and my left underarm had pain. Monday tiredness gone but (pain, itch and 4 inch diameter rash at injection site. In left ear had tenderness and left underarm had pain) remained. On Tuesday I consulted with a pharmacist at the pharmacy where vaccine was administered and upon inspection was advised to place cold compress on injection site to remove swelling; and take ibruprophen for pain 3 times a days. I applied cold compres and took ibruprophen once a day. Today Thursday the swelling remains but the itch and rash are almost gone. Left inner ear and underarm tenderness has gone.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strenth of vaccine remained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive work contact
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Influenza virus test negative, Injection site erythema, Injection site mass
Clinical narrative: It started with a minor reaction and started getting redder and warm to the touch and spread down from the injection site to my elbow and half in my inner arm. And a lump under my shoulder. Sore throat, congestion, cough, headache, fever.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Oropharyngeal pain, Pyrexia, Respiratory syncytial virus test negative, Respiratory tract congestion
Clinical narrative: It started with a minor reaction and started getting redder and warm to the touch and spread down from the injection site to my elbow and half in my inner arm. And a lump under my shoulder. Sore throat, congestion, cough, headache, fever.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: It started with a minor reaction and started getting redder and warm to the touch and spread down from the injection site to my elbow and half in my inner arm. And a lump under my shoulder. Sore throat, congestion, cough, headache, fever.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Night blindness
Clinical narrative: 24 hours post vaccine, patient experienced altered and degraded night vision.  In dark and low light environments with the presence of light sources, patient felt vision was not normal.  Abnormal vision was more noticeable when patient was moving and or visually scanning the room.  Daylight vision was normal.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Neck pain, Pruritus
Clinical narrative: On the second day of 3rd dose patient complains of pain in the neck. at the third day the patient state that she had pain in the area and itchy.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypomenorrhoea, Menstrual disorder, Menstruation irregular
Clinical narrative: My periods have been very irregular since receiving the vaccine. I have never experienced irregular cycles prior and could always assume my cycles would be 32 days start to finish. Any variation experienced was a couple days late at most.  My first cycle after the vaccine was two weeks late and every one since then has been very early or very late. My cycle length now has varied from 16 days to 50 days. All cycles except one have been normal in flow. The 16 day cycle was unusually light. I received the vaccine over six months ago and my cycles have not gone back to normal.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: The nurse sated that she reconstituted the 5-11 year old  Pfizer Covid-19 vaccine with 1.8 ml of 0.9% of normal saline instead of 1.3 ml.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 10/11/2021. PATIENT FULLY VACCINATED ON 04/16/2021.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Injection site swelling, Pain in extremity, Somnolence
Clinical narrative: 11/13/2021- Participant begin very sleepy, had extreme arm pain and a bump on the injection site, and very sweaty. 11/13/2021- Telehealth consultation was informed to give plenty of fluids and rest.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strenth of vaccine remained.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 28.0
Sex: F
Vaccine: FLU4
Symptoms: Wrong technique in product usage process
Clinical narrative: Patient received influenza vaccine with a pediatric size needle. Patient was instructed they should seek another influenza vaccination IM
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strength of vaccine remained.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid positive contact with friend  Booster was given 10/29/21
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain, Pyrexia
Clinical narrative: Fever, chills, nausea, fatigue, whole body pain.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: BREAKTHROUGH COVID INFECTION. PATIENT TESTED POSITIVE ON 10/19/2021. PATIENT FULLY VACCINATED ON 09/15/2021.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strenth of vaccine remained.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: The patient was inadvertently administered 0.25 ml of Moderna instead of 0.5 ml Moderna second dose in primary series. Patient were monitored 15 minutes without issue and left clinic. Error noticed during data entry into Roster.  Medical provider notified and recommended the following. CDC recommendations of another 0.25 ml injection be given on the same day for optimal benefits. If patient refuses to come back for this dose, CDC will recognize 0.25 ml as an adequate second dose in the primary series. Therefore, in 6 months patients will be eligible for booster dose of 0.25 ml in 6 months.  Patient notified and returned the same day. An additional 0.25 ml dose of Moderna was administered to the patient. Patient was monitored 15 minutes without issues.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Dermatitis, Eczema, Immune system disorder, Rash pruritic
Clinical narrative: Went to PCP. Chronic Hives. Referred to allergy and asthma specialist. Treated with Xolair shots. Hives got . better. Also diagnosed with Dermatitis and exzema. Itchy bumps all over body. On Dupexit. Suspected over-active immune system. Symptoms continued and worsened with 2nd vaccine (IM, RA, Pfizer EW0153, 04/15/2021).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Went to PCP. Chronic Hives. Referred to allergy and asthma specialist. Treated with Xolair shots. Hives got . better. Also diagnosed with Dermatitis and exzema. Itchy bumps all over body. On Dupexit. Suspected over-active immune system. Symptoms continued and worsened with 2nd vaccine (IM, RA, Pfizer EW0153, 04/15/2021).
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis revealed full strenth of vaccine remained.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein normal, Full blood count normal, Metabolic function test normal, Neuralgia, Rash
Clinical narrative: 5 days post vaccination severe onset of dull lower rib cage anteriorly and posteriorly with gradual onset of papulo-vesicular rash starting a week later and peaking at following 7 days with classical H. Zoster rash along the lower ribs cage course both posteriorly (max rash) and anteriorly and gradual resolution but neuralgia persisting. Treatment with gabapentin and Valtrex initiated and continued until complete vesicular eruption resolution.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Rash papular, Rash vesicular
Clinical narrative: 5 days post vaccination severe onset of dull lower rib cage anteriorly and posteriorly with gradual onset of papulo-vesicular rash starting a week later and peaking at following 7 days with classical H. Zoster rash along the lower ribs cage course both posteriorly (max rash) and anteriorly and gradual resolution but neuralgia persisting. Treatment with gabapentin and Valtrex initiated and continued until complete vesicular eruption resolution.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiospasm, Computerised tomogram, Electrocardiogram, Electroencephalogram, Magnetic resonance imaging
Clinical narrative: heart palpations heart spams fainting convulsion
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Seizure, Syncope, Ultrasound scan
Clinical narrative: heart palpations heart spams fainting convulsion
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arteriospasm coronary, Dizziness, Palpitations, SARS-CoV-2 test, Seizure
Clinical narrative: heart palpations heart spams fainting convulsion
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: heart palpations heart spams fainting convulsion